加载中
HKSEHealthcareMedical - Care Facilities
最新数据
HK$0.70
+HK$0.005 · +0.72%
Concord Healthcare Group Co., Ltd. is dedicated to providing comprehensive cancer treatment services for patients and healthcare institutions throughout China. Its operations extend beyond direct care to include the distribution and installation of medical hardware and software, along with offering management and technical assistance, and providing equipment via operating leases. The company was founded in 2008 and is headquartered in Beijing, China. It functions as a subsidiary of Shanghai Medstar Financial Leasing Company.
最新数据
HK$0.70
+HK$0.005 · +0.72%
盘中时间采用HKT。市场数据可能有所延迟。
Concord Healthcare Group Co., Ltd. is dedicated to providing comprehensive cancer treatment services for patients and healthcare institutions throughout China. Its operations extend beyond direct care to include the distribution and installation of medical hardware and software, along with offering management and technical assistance, and providing equipment via operating leases. The company was founded in 2008 and is headquartered in Beijing, China. It functions as a subsidiary of Shanghai Medstar Financial Leasing Company.
日内区间
当前HK$0.70
52周区间
当前HK$0.70
盘中时间采用HKT。市场数据可能有所延迟。
Concord Healthcare Group Co., Ltd. is dedicated to providing comprehensive cancer treatment services for patients and healthcare institutions throughout China. Its operations extend beyond direct care to include the distribution and installation of medical hardware and software, along with offering management and technical assistance, and providing equipment via operating leases. The company was founded in 2008 and is headquartered in Beijing, China. It functions as a subsidiary of Shanghai Medstar Financial Leasing Company.
日内区间
当前HK$0.70
52周区间
当前HK$0.70
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（CNY） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 4.48亿 CNY | 3.88亿 CNY | 5.39亿 CNY | 4.72亿 CNY | 4.71亿 CNY |
| 销货成本 | 4.17亿 CNY | 4.56亿 CNY | 6.04亿 CNY | 7.47亿 CNY | 6.6亿 CNY |
| 毛利 | 3112.31万 CNY | −6724.8万 CNY | −6508.9万 CNY | −1.97亿 CNY | −9275.54万 CNY |
| 研究与开发 | 2744.29万 CNY | 3118.4万 CNY | 3644.3万 CNY | 4131.6万 CNY | 4038.1万 CNY |
| 销售、一般及管理费用 | 1.87亿 CNY | 2.59亿 CNY | 2.53亿 CNY | 2.74亿 CNY | 1.03亿 CNY |
| 营业费用 | 2.63亿 CNY | 3.3亿 CNY | 2.89亿 CNY | 3.59亿 CNY | 3.76亿 CNY |
| 利息收入 | 65.85万 CNY | 73.3万 CNY | 728.1万 CNY | 778.6万 CNY | 546.7万 CNY |
| 利息支出 | 1.2亿 CNY | 1.09亿 CNY | 1.08亿 CNY | 2.74亿 CNY | 4.35亿 CNY |
| 折旧和摊销 | 1.53亿 CNY | 1.14亿 CNY | 1.52亿 CNY | 1.48亿 CNY | 1.14亿 CNY |
| 营业利润 | −2.32亿 CNY | −3.71亿 CNY | −3.54亿 CNY | −4.78亿 CNY | −3.93亿 CNY |
| 净利润 | −2.5亿 CNY | −4.43亿 CNY | −3.73亿 CNY | −5.41亿 CNY | −8.17亿 CNY |
公司数据更新于 2026年10月13日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
